Skip to main content

Men's health device support

GreenLight™ Laser Therapy

Understanding your treatment

GreenLightTM Laser Therapy uses laser technology to treat benign prostatic hyperplasia (BPH), also called an enlarged prostate. Over one million men worldwide have been treated with GreenLight Laser Therapy for BPH.1

GreenLight Laser Therapy procedure

How it works

GreenLight Laser Therapy treats BPH by vaporizing obstructive prostate tissue. During your procedure, your doctor uses innovative laser technology to remove your overgrown prostate tissue and to help restore natural urine flow. 


Potential Benefits of GreenLight Laser Therapy*

Men typically experience symptom relief as soon as 2 weeks after treatment, with improvements continuing for up to 3 months.2 When compared to traditional surgery, GreenLight Laser Therapy can provide several advantages including:²⁻⁷

  • Shorter hospital stay 
  • Shorter catheterization time
  • Less bleeding 
  • Faster recovery
  • Recommended for high-risk patients (ex. High blood pressure, blood thinner medications)8

Knowing the side effects*

GreenLight Laser Therapy restores natural urine flow, often within 24 hours of the procedure.² As with all surgical treatments, there are risks and side effects, and you should speak with your doctor about them before moving forward with any treatment option. Patients using GreenLight Laser Therapy in some cases have reported irritative symptoms (such as urgency or frequency urinating), bleeding, retrograde ejaculation (semen enters the bladder instead of releasing from the penis during ejaculation) and urinary tract infection.


Recovering from your procedure*

Your doctor will discuss further instructions during your follow-up visit. In general, here are a few things you can expect from your recovery:

  • Having a catheter for about a day after the procedure2
  • Having an outpatient procedure, meaning an overnight hospital stay isn't require
  • Resuming normal activities within a couple of days2

Regular follow-up visits*

It’s important to maintain follow-up visits, even if you’re feeling well. During these visits, your doctor may will monitor your progress, evaluate your medications, check the status of your overall health and determine the outcome of your treatment.

We're here to help

Our patient services team is here to support you throughout your journey.

(781) 549-3994

References:

  1. Data on file with Boston Scientific.
  2. Bachmann A, Tubaro A, Barber N, et al. 180-W XPS GreenLight laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of the European multi-centre randomized trial – The GOLIATH Study. Eur Urol. 2014 May;65(5):931-42.
  3. Lukacs B, Loeffler J, Bruyère F, et al. Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: A multicenter randomized controlled trial. Eur Urol. 2012;61(6):1165-73.
  4. Capitán C, Blázquez C, Martin MD, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: A randomized clinical trial with 2-year follow-up. Eur Urol. 2011 Oct;60(4):734-9.
  5. Al-Ansari A, Younes N, Sampige VP, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol. 2010 Sep;58(3):349-55.
  6. Bouchier-Hayes DM, Van Appledorn S, Bugeja P, et al. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int. 2010 Apr;105(7):964-9.
  7. Garnick MB. 2013 Annual Report on Prostate Diseases. Boston, MA: Harvard Health Publications; 2013.
  8. Lerner LB, McVary, KT, Barry MJ, et al.: Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline part I, initial work-up and medical management. J Urol. 2021 Oct;206(4):806-17.
  9. Thomas JA, Tubaro A, Barber N, et al. The continuing story of the cost-effectiveness of photoselective vaporization of the prostate versus transuretheral resection of the prostate for the treatment of symptomatic benign prostatic obstruction. Value Health. 2015 Jun;18(4):376-86.

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

All images are the property of Boston Scientific. All trademarks are the property of their respective owners. Content of this web site is for Informational Purposes only and does not constitute medical advice and should not be used for medical diagnoses. Boston Scientific strongly recommends that you consult with your physician on all matters pertaining to your health or to address any clinical/medical questions. All surgical treatments have inherent and associated risks. The GreenLight Laser System is intended for the removal of soft tissue, including vaporization of the prostate for benign prostatic hyperplasia (BPH). Potential risks include irritative symptoms, bleeding, retrograde ejaculation and urinary tract infection. You should talk with your doctor about benefits and risks before moving forward with any treatment option.

*Results from case studies are not necessarily predictive of results in other cases. Results may vary.